Key result
First- and second-generation antipsychotic use was not associated with unexplained sudden deaths in psychiatric patients, whereas comorbid dyslipidemia and diabetes were more common.
Why the study?
Are unexplained sudden deaths in psychiatric patients associated with higher utilization of antipsychotics compared to explained sudden deaths?
Cohort (n=100)
No
Are unexplained sudden deaths in psychiatric patients associated with higher utilization of antipsychotics compared to explained sudden deaths?
Answers are grounded in this paper and cite their sources.
Unexplained sudden deaths in psychiatric patients appear to be associated with metabolic risk factors like diabetes and dyslipidemia rather than the use of antipsychotic medications.
BACKGROUND: Studies using death certificates have indicated an excess of sudden cardiac deaths among users of antipsychotic drugs compared to the general population, but they may have underestimated the presence of other known causes of sudden and unexpected death. OBJECTIVE: To assess the causes and risk factors for sudden death discovered by contemporaneous investigation of all deaths occurring over a 26-year period (1984-2009) in adults (119,500 patient-years) receiving care in one large psychiatric hospital in New York. METHOD: Circumstances of death, psychiatric diagnoses, psychotropic drugs, and past medical history were extracted from the root cause analyses of sudden, unexpected deaths. After cases involving suicide, homicide, and drug overdoses were excluded, the remaining explained and unexplained cases of sudden death were compared regarding clinical variables and the utilization of antipsychotics. RESULTS: One hundred cases of sudden death were identified. The death remained unexplained in 52 cases. The incidence of unexplained sudden death per 100,000 patient-years increased from 7 (95% CI, 3.7-19.4) in 1984-1998 to 125 (95% CI, 88.9-175.1) in 2005-2009. Explained and unexplained cases were similar regarding psychiatric diagnoses and use of all psychotropic classes, including first- and second-generation antipsychotics. Dyslipidemia (P = .012), diabetes (P = .054), and comorbid dyslipidemia and diabetes (P = .006) were more common in the unexplained group. CONCLUSIONS: In a consecutive cohort of psychiatric patients, the unexplained sudden deaths were not associated with higher utilization of first- or second-generation antipsychotics. The role of diabetes and dyslipidemia as risk factors for sudden death in psychiatric patients requires careful longitudinal studies.
No takes yet. Share an insight, caveat, or question.
Manu et al. (2011) conducted a cohort in Psychiatric patients (n=100). First- and second-generation antipsychotics vs. Non-users was evaluated on Utilization of first- or second-generation antipsychotics in unexplained versus explained sudden death cases. First- and second-generation antipsychotic use was not associated with unexplained sudden deaths in psychiatric patients, whereas comorbid dyslipidemia and diabetes were more common.
Synapse has enriched 10 related papers. Consider them for comparative context: